EPO Gets Access to India's Traditional Knowledge Digital Library (TKDL)

The ambitious traditional knowledge digital library (TKDL), successfully completed by CSIR (under VK Gupta's stewardship) is now accessible to the EPO, thanks to an agreement signed recently between the Indian government and the EPO.

Radhika Pandeiya and Jacob Koshy of The Mint broke this story (online) today, including myriad comments on what this means for India in terms of the much bandied about TK misappropriation debates (turmeric patenting etc). And what ought to the future policy direction in relation to this database and its potential access to non governmental entities.Here are some excerpts from their story titled "Ginger can’t be patented in Europe now"

"India’s traditional knowledge—such as medicinal properties of neem and turmeric—could now become more difficult to patent for drug makers in Europe. The European Patent Office, or EPO, will consult an Indian database that lists traditionally known drug formulations before granting patent rights. The Council for Scientific and Industrial Research, or CSIR, India’s largest state-managed research agency, will begin sharing the home-grown catalogue with EPO later this month. CSIR and EPO recently signed an access agreement to this effect. This will likely result in at least 40 patent filings in Europe getting rejected, which could have otherwise passed muster.

The Traditional Knowledge Digital Library, or TKDL, has been created by the National Institute of Science Communication and Information Resources, or Niscair, a CSIR body, and contains a 24-million-page searchable database that translates text from Sanskrit into English, German, French, Spanish and Japanese. A CSIR official said that though 2,000 existing patents can now be challenged, there were no plans to initiate litigation. “This is meant as a deterrent, though technically we can initiate litigation saying that these patents are based on well-known formulations, it would be too expensive and long-drawn,” the official said on condition of anonymity.

“This is a very positive step for us in protecting traditional knowledge. It’s a big achievement,” Samir Brahmachari, director general of CSIR, said over the phone. The next step is to take this initiative to the US. India did fight successfully the revocation of patent on wound healing property of turmeric at United States Patent and Trademark Office and (a) patent on anti-fungal properties of neem at European Patent Office,” Niscair director V.K. Gupta, who is also lead coordinator for the project, said in a 2006 report. “However...(a) legal battle on revocation is extremely expensive and time consuming.”

For anything to be granted a patent, the applicant must prove that it is novel and not previously known. “Indian traditional knowledge is prior art, which means it is already known publicly. Hence, once TKDL opens out to EPO, anyone applying for a patent on which we hold traditional knowledge will not be successful,” said Elizabeth Varkey, an advocate at the Kerala high court.

EPO, however, is unsure of the extent to which TKDL will be applicable. “Many cases affected by aspects of traditional knowledge are occurring in the field of medicinal preparations. We estimate that at the EPO, about 100 patent applications per year are related to such aspects, but not all of them relate to subjects covered by TKDL,” Osterwalder said.

There is an argument that the database be used other ways too. “The government should also think about negotiating access rights (to TKDL) to private parties and other non-governmental entities. Given that the new chemical entities pipeline is drying up, innovators need to focus more on traditional knowledge that offer potentially unique insights for new drugs,” said Shamnad Basheer, professor of intellectual property law at the National University of Juridical Sciences, Kolkata. “Also private parties could then challenge patent applications that misappropriate Indian traditional knowledge.”

  1. Visit http://www.tkdl.res.in/tkdl/langdefault/common/home.asp?GL=Eng. This is a collaborative project of CSIR and Department of Ayurveda Yoga & Naturopathy Unani, Siddha and Homeopathy (AYUSH).
  2. “Ginger Can’t Be Patented in Europe Now”, February 6, 2009 http://www.livemint.com/2009/02/05214415/Ginger-can8217t-be-patented.html
  3. Visit IPPro’s database at http://www.ipproinc.com/usefulinformation_links.php?sub_id=54 to know more about “Traditional Knowledge”.
  4. Section 3 (p) The Patents Act, 1970 “an invention which, in effect,is traditional knowledge or which is an aggregation or duplication of known properties of traditionally known component or components”, is not considered an invention under the Act.”
  5. Also read "Prevention Is Better Than Cure-CSIR Moves To Protect Traditional Knowledge In Europe!"

Be part of XTractor community.

  • XTractor the first of its kind - Literature alert service, provides manually curated & annotated sentences for the Keywords of your choice
  • XTractor maps, extracted entities (genes, processes, drugs, diseases etc) to multiple ontologies
  • Enables customized report generation. With XTractor the sentences are categorized into biologically significant relationships
  • The categorized sentences could then be tagged and shared across multiple users
  • Provides users with the ability to create his own database for a set of Key terms
  • Users could change the Keywords of preference from time to time, with changing research needs
  • XTractor thus proves to be a platform for getting real-time highly accurate data along with the ability to Share and collaborate


Sign up it's free, and takes less than a minute. Just click here:www.xtractor.in.











Comments

Popular posts from this blog

Sequence Analysis is still sexy:Dual Descriptor Method for Biological Sequence Analysis

Abbott Laboratories Buys Piramal Healthcare Limited Biz for $3.72B

List of Cheminformatics Companies & Institutions